Clinical Trial of Sodium Nitrite for Out of Hospital Cardiac Arrest
A phase 2/3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 1502 participants.
Also called NCT03452917
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 2/3
- Enrolled
- 1,502 participants
- Registry
-
NCT03452917
-
- Other papers using this trial's data
- Effect of Out-of-Hospital Sodium Nitrite on Survival to Hospital Admission After Cardiac Arrest: A Randomized Clinical Trial
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT03452917. Randomized; quadruple masking; primary purpose treatment. Start 2018-02-08 (actual); primary completion 2019-12-31 (actual). Results posted on 2023-05-24.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Clinical Trial of Sodium Nitrite for Out of Hospital Cardiac Arrest
- Acronym
- SNOCAT
- Condition
- Out-Of-Hospital Cardiac Arrest
- Intervention (Drug)
- Placebo
- Intervention (Drug)
- sodium nitrite 45 mg
- Intervention (Drug)
- sodium nitrite 60 mg
- Lead sponsor
- University of Washington
- Collaborator
- National Heart, Lung, and Blood Institute (NHLBI)
Record details
- Record id
cardio:ct-nct03452917- Content hash
21d80b2a6c3c537126e1c971198ac6476973831633296d483bc5ed31f1c46b41